Related Experiment Video
Updated: Jun 14, 2025
Evaluation of Zika Virus-specific T-cell Responses in Immunoprivileged Organs of Infected Ifnar1-/- Mice
Published on: October 17, 2018
Harnessing endogenous miRNA targeting ZIKV: A cutting-edge strategy to inhibit virus infection
Rhubia S M Rosa1,2, Soledad Palameta1,3, Jessica M Toscaro1,4
1Brazilian Biosciences National Laboratory, Brazilian Center for Research in Energy and Materials, Campinas, São Paulo, Brazil.
Abstract:
Emerging RNA virus outbreaks, including Zika virus, highlight the urgent need for novel antiviral strategies. Zika virus, a positive-strand RNA virus, causes congenital Zika syndrome, and to date, there are no approved vaccines or antiviral treatments. In this context, microRNAs are small non-coding RNAs that regulate gene expression and show potential as antiviral agents due to their ability to target viral RNA, making them a promising therapeutic approach against Zika syndrome. In this study, we identified endogenous microRNAs that interact with the virus genome using computational algorithms and overexpressed them in VERO cells. Twelve microRNAs reduced viral cytopathic effects by more than 50% in cells infected with a Brazilian Zika virus strain. Additionally, we used a computational platform to select pharmacological compounds capable of modulating endogenous microRNAs in human cells, achieving over 90% inhibition of Zika virus activity. These findings offer a promising path through drug repurposing for antiviral therapy by modulating endogenous microRNAs, with potential applications for other positive-strand RNA viruses.
Insights
Researchers identified microRNAs (miRNAs) that fight Zika virus. Overexpressing these miRNAs and using drug repurposing inhibited over 90% of viral activity, offering new antiviral strategies.
Area of Science:
- Virology
- Molecular Biology
- Genetics
Background:
- Emerging RNA virus outbreaks, such as Zika virus, necessitate novel antiviral therapies.
- Zika virus causes congenital Zika syndrome, with no current vaccines or treatments.
- MicroRNAs (miRNAs) are small non-coding RNAs with potential as antiviral agents targeting viral RNA.
Purpose of the Study:
- To identify endogenous miRNAs that interact with the Zika virus genome.
- To evaluate the antiviral efficacy of overexpressing these miRNAs in VERO cells.
- To explore drug repurposing for antiviral therapy by modulating endogenous miRNAs.
Main Methods:
- Computational algorithms were used to identify miRNAs targeting the Zika virus genome.
- Selected miRNAs were overexpressed in VERO cells infected with a Brazilian Zika virus strain.
- A computational platform identified pharmacological compounds to modulate endogenous miRNAs for antiviral effects.
Main Results:
- Twelve endogenous miRNAs reduced Zika virus-induced cytopathic effects by over 50%.
- Drug repurposing via miRNA modulation achieved over 90% inhibition of Zika virus activity.
- These findings demonstrate a promising therapeutic approach for Zika virus infection.
Conclusions:
- Modulating endogenous microRNAs presents a viable strategy for antiviral therapy against Zika virus.
- Drug repurposing offers a rapid path to developing treatments by targeting host miRNAs.
- This approach holds potential for combating other positive-strand RNA viruses.
Related Concept Videos
01:22MicroRNAs
02:15Experimental RNAi
02:30siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
01:23RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...